Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€21.36
13.10.22
€20.00
13.10.23
-48.44%
11.01.23

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Columbia Care Inc.

Start price
Target price
Perf. (%)
€1.59
13.10.22
€1.90
13.10.23
-54.52%
11.01.23

Capable Management
Innovative
Bad rating
Few uniques
buy
Carbios S.A.

Start price
Target price
Perf. (%)
€23.36
13.10.22
€30.60
20.09.23
0.17%
21.09.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€39.30
13.10.22
-
13.10.23
-0.71%
14.10.23

buy
Ströer SE

Start price
Target price
Perf. (%)
€41.48
13.10.22
-
13.10.23
4.10%
14.10.23

buy
Siemens Energy AG

Start price
Target price
Perf. (%)
€10.70
13.10.22
€15.00
13.10.23
-3.23%
13.10.22

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.38
13.10.22
€46.00
13.10.23
9.44%
14.10.23

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Hyundai Motor Co ADR

Start price
Target price
Perf. (%)
€28.40
13.10.22
€40.00
13.10.23
27.11%
14.10.23

Could be very worthwhile Investment >20% year
Fair valuation
Normal challenges to pay loans and raise capital
Good rating
buy
Lithium Americas Corp.

Start price
Target price
Perf. (%)
€22.71
13.10.22
€34.00
13.10.23
-33.54%
14.10.23

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Very low/no dividend yield expected
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€71.02
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
GSK plc

Start price
Target price
Perf. (%)
€15.62
13.10.22
€20.00
13.10.23
11.01%
14.10.23

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
buy
Base Resources Ltd

Start price
Target price
Perf. (%)
€0.16
13.10.22
€0.30
13.10.23
-46.04%
14.10.23

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Medium risks for its business
buy
BYD Co. Ltd

Start price
Target price
Perf. (%)
€25.55
13.10.22
€43.00
13.10.23
-5.70%
24.10.22

Could be worthwhile Investment >10% per year
EBIT growth > 30% per year expected
Revenue growth > 30% per year expected
Good rating
buy
Cameco Corp.

Start price
Target price
Perf. (%)
€23.13
12.10.22
€62.00
12.01.27
51.23%
02.08.24

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very Future proof/growth oriented business model
buy
About You Holding AG

Start price
Target price
Perf. (%)
€6.25
12.10.22
-
12.10.23
-21.63%
13.10.23

buy
Credit Agricole Inh.

Start price
Target price
Perf. (%)
€8.30
12.10.22
€12.00
09.08.23
31.25%
06.06.23

Higher EBIT margin than peer group
High dividend yield expected
positive Cash Flow expected
Little innovation
buy
Hornbach Baumarkt AG

Start price
Target price
Perf. (%)
€47.50
11.10.22
€50.00
-
12.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Hornbach Holding AG & Co. KGaA

Start price
Target price
Perf. (%)
€68.25
11.10.22
-
11.10.23
-11.50%
12.10.23

buy
Hypoport SE

Start price
Target price
Perf. (%)
€88.85
11.10.22
€90.00
11.10.23
-2.98%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
buy
Hypoport SE

Start price
Target price
Perf. (%)
€88.85
11.10.22
-
11.10.23
41.81%
11.10.23

Deutsche Post AG

Start price
Target price
Perf. (%)
€32.34
10.10.22
-
10.10.23
35.58%
05.05.23

Higher risks for its business
EBIT decline/stagnation expected
buy
Pulmatrix Inc.

Start price
Target price
Perf. (%)
€3.77
10.10.22
€6.00
31.12.24
-30.11%
05.05.23

Could be very worthwhile Investment >20% year
buy
Aileron Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
10.10.22
€0.50
31.12.24
-24.88%
21.12.22

Could be very worthwhile Investment >20% year
buy
Plus Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.85
10.10.22
€15.00
31.12.24
-46.85%
21.12.22

Could be very worthwhile Investment >20% year
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€1.97
10.10.22
€0.000
10.10.23
-6.09%
16.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group